Annemarie Moseley, COO/EVP Clinical Development at BELLICUM PHARMACEUTICALS, INC (BLCM), sold 25,000 shares at $13.00 ($325K) on 2016-06-02, disclosed to the SEC on 2016-06-06.
Open-market sale of $325k BLCM by COO/EVP Clinical Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.00 | 6,765 | $88K | 27.1% |
| 2 | $13.00 | 18,235 | $237K | 72.9% |
| Total | $13.00 avg | 25,000 | $325K | 100% |
| Filing → |
| BLCM | SELL | 2015-07-06 | $722K | — | Filing → |